Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a 'Nervous System' therapy help people with obesity tune into their bodies?

NCT ID NCT07315763

Symptom relief Sponsor: Royal Holloway University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a 6-session group therapy based on polyvagal theory, designed to help people with obesity become more aware of body signals and better manage emotions. Ten participants from an NHS weight management service will be randomly assigned to start the therapy after 14 or 21 days. They will track daily changes in body awareness, emotional regulation, and skills practice. The goal is to see if this approach can improve the mind-body connection and reduce emotional eating.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
polyvagal-informed group skills training (behavioural therapy)
What this could lead to
If it works, this could offer a new therapy to help people with obesity better understand body signals and manage emotions, potentially reducing emotional eating.
What could go wrong
This is a very small early study with only 10 participants, so results may not apply to everyone. It's not yet recruiting, and the intervention is behavioural, so effects may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Able to commit to the duration of the study from baseline to end of follow up period (up to 16 weeks) * Current service user of Specialist Weight Management Programme * Aged 18-65. * Good level of English spoken, reading and writing. * Identified by the University of Rhode Island Change Assessment (URICA) to be in the Contemplation, Action or Maintenance stage of change. * Access to device with internet connection to complete online questionnaires and with camera for online group sessions. Exclusion Criteria: * Identified by the University of Rhode Island Change Assessment (URICA) to be in Pre-contemplation stage of change * Currently in psychological skills training treatment during the 16-week study period * History of organic brain injury or cognitive impairment * Clients presenting with suicidal intent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Body awareness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Emotional Regulation Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Body awareness Emotional regulation Obesity

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ashford and St Peter's Hospital NHS Foundation Trust

    Ashford, Surrey, TW15 3AA, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.